drugset / Trial / NCT02583828

Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

NCT02583828

Completed 200 enrolled Capital Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized clinical trial to investigate the efficacy of letrozole combined with metronomic oral cyclophosphamide in elderly metastasis breast cancer patients.

Timeline

Start
2015-06
Primary completion
2020-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 50 mg
Subject Letrozole Other / unclassified 2.5 mg